pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,268 catalysts · 3,350 8k filing · 2,402 grant · 2,350 approval · 1,681 device 510k · 1,204 device recall · 1,151 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-02×clear all
type
  • 8k filing3,350
  • grant2,402
  • approval2,350
  • device 510k1,681
  • device recall1,204
  • device pma1,151
device adverse event
1,000
  • earnings584
  • recall465
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 20, 2025

    50
    ›Oct 23, 2025device 510k296d agoAlign Technology, Inc. — Invisalign® Palatal Expander System (510k cleared)ALIGN TECHNOLOGY INC

    Product code: NXC. Advisory committee: Dental. Type: Special

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoAsclepion Laser Technologies GmbH — MultiPulse TFL (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoHartalega NGC Sdn. Bhd. — Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl in Simulated Gastric Acid (Black) (510k cleared)Teva Pharmaceuticals USA Inc

    Product code: LZA. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoSa3, LLC — Silatrix Oral Gel (510k cleared)

    Product code: OLR. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoRisu Medical Technology Co., Ltd. — Picosecond Laser Device (PF131-BI) (510k cleared)NewBay Medical Technology Co Ltd

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoTerrats Medical SL — DESS® Dental Smart Solutions (510k cleared)

    Product code: NHA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoZhengzhou PZ Laser Slim Technology Co., Ltd. — 1927nm Thulium Laser System (PZ-DJG75-01, PZ-DJG75-02) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoUroviu Corporation — UV5000W Handle (510k cleared)

    Product code: FAJ. Advisory committee: Gastroenterology, Urology. Type: Special

    full page →fda device 510k ↗
    ›Oct 23, 2025device 510k296d agoTerarecon,Inc. — TeraRecon Cardiovascular.Calcification.CT (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 23, 2025device pma296d agoABBOTT MEDICAL — Amplatzer™ Muscular VSD Occluder (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MLV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoBoston Scientific Corporation — ENROUTE® Transcarotid Stent System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoABBOTT MEDICAL — Amplatzer™ Duct Occluder; Amplatzer™ Duct Occluder II; Amplatzer Piccolo™ Occluder (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MAE. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Mosaic Bioprosthesis, Models 305, 310 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: DYE. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoABBOTT MEDICAL — Amplatzer™ Amulet™ Left Atrial Appendage Occluder (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NGV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Freestyle Bioprosthesis, Models 995, 995CS, 995MS (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic Vascular — Endurant II/IIs Stent Graft System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: MHY. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Avalus Bioprosthesis, Model 400 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic Neuromodulation — Master Restore™, Itrel™, Synergy™, Intellis™, Vanta™ and Inceptiv™ Spinal Cord Stimulation Systems and Pisces-Quad™, Spe (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LGW. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoBiotronik Nro, Inc. — Prospera SCS System; Resilience Percutaneous Lead; Embrace One; TrueLock (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LGW. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Melody™ Transcatheter Pulmonary Valve (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoABBOTT MEDICAL — Amplatzer™ Septal Occluder; Amplatzer™ Multi-Fenestrated Septal Occluder - Cribriform (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MLV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoABBOTT MEDICAL — Amplatzer™ PFO Occluder; Amplatzer™ Talisman™ PFO Occluder (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MLV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Hancock II Bioprosthesis, Models T505, T510 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: DYE. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoNovocure, GmbH — Optune Gio™ - Maxpoint Version 2.0 (PMA supplement)NovoCure Ltd

    Supplement type: Normal 180 Day Track. Product code: NZK. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Oct 23, 2025device pma296d agoMedtronic, Inc. — Harmony™ Transcatheter Pulmonary Valve (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 23, 2025device recall296d agoDatascope Corp. device recall (Cls III)

    Cardiosave Rescue — Reason: The IFU addendum updates the Vibration and Shock Table to reference the correct standards. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 23, 2025device recall296d agoDatascope Corp. device recall (Cls III)

    Cardiosave Hybrid — Reason: The IFU addendum updates the Vibration and Shock Table to reference the correct standards. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 23, 2025device recall296d agoBecton Dickinson & Co. device recall (Cls II)BECTON DICKINSON & CO

    BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; — Reason: The 2D barcodes on these cuvettes contain formatting errors that prevent the analyzing system from correctly reading the expiration date. As a result, the instrument enters an error state and the cuvettes cannot be used. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 24, 2025approval295d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoWINREVAIR (SOTATERCEPT-CSRK) — FDA approvalsotatercept

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →sotatercept →fda approvals ↗
    ›Oct 24, 2025approval295d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Oct 24, 2025approval295d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 24, 2025approval295d agoTRAMADOL HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 24, 2025approval295d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: HIKMA. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Oct 24, 2025approval295d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Oct 24, 2025approval295d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoLEFLUNOMIDE — FDA approvalLEFLUNOMIDE

    Sponsor: HERITAGE. Form: TABLET. Route: ORAL

    full page →LEFLUNOMIDE →fda approvals ↗
    ›Oct 24, 2025approval295d agoSYNJARDY XR (EMPAGLIFLOZIN) — FDA approval(empagliflozin + metformin hydrochloride ER)

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →(empagliflozin + metformin hydrochloride ER) →fda approvals ↗
    ›Oct 24, 2025approval295d agoLYNKUET (ELINZANETANT) — FDA approvalBayer USA LLC

    Sponsor: BAYER HLTHCARE. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoREVUFORJ (REVUMENIB CITRATE) — FDA approvalrevumenib citrate

    Sponsor: SYNDAX. Form: TABLET. Route: ORAL

    full page →revumenib citrate →fda approvals ↗
    ›Oct 24, 2025approval295d agoCOPIKTRA (DUVELISIB) — FDA approvalSecura Bio Inc

    Sponsor: SECURA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoGLYXAMBI (EMPAGLIFLOZIN) — FDA approval(empagliflozin + linagliptin)

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →(empagliflozin + linagliptin) →fda approvals ↗
    ›Oct 24, 2025approval295d agoLETROZOLE — FDA approvalHikma Pharmaceuticals Plc

    Sponsor: HIKMA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 24, 2025approval295d agoANASTROZOLE — FDA approvalANASTROZOLE

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →ANASTROZOLE →fda approvals ↗
    ›Oct 24, 2025approval295d agoSYNJARDY (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →SYNJARDY →fda approvals ↗
    ›Oct 24, 2025approval295d agoTRIJARDY XR (EMPAGLIFLOZIN) — FDA approval(empagliflozin + linagliptin + metformin hydrochloride) ER

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →(empagliflozin + linagliptin + metformin hydrochloride) ER →fda approvals ↗
    ›Oct 24, 2025approval295d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

    Sponsor: B BRAUN MEDICAL. Form: SOLUTION. Route: INTRAVENOUS

    full page →ROCURONIUM BROMIDE →fda approvals ↗
    ›Oct 24, 2025approval295d agoJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →SYNJARDY →fda approvals ↗
    ← prev
    page 16 of 286
    next →
    $ALGN
    $MDT91.27+0.76%
    $MDT91.27+0.76%
    $MDT91.27+0.76%
    $BSX51.83+0.27%
    $MDT91.27+0.76%
    $NVCR20.05+28.74%
    $MDT91.27+0.76%
    $MDT91.27+0.76%
    $MDT91.27+0.76%
    $BDX183.40+0.79%
    $AMRX18.15+5.10%
    $SNDX19.84+3.98%